These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37232749)

  • 41. Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.
    Hunger RE; Laffitte E; Läuchli S; Mainetti C; Mühlstädt M; Schiller P; Lapointe AK; Meschberger P; Navarini AA
    Dermatology; 2017; 233(2-3):113-119. PubMed ID: 28683447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An update on the pathogenesis of hidradenitis suppurativa: implications for therapy.
    Negus D; Ahn C; Huang W
    Expert Rev Clin Immunol; 2018 Apr; 14(4):275-283. PubMed ID: 29509041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hidradenitis suppurativa.
    Buimer MG; Wobbes T; Klinkenbijl JH
    Br J Surg; 2009 Apr; 96(4):350-60. PubMed ID: 19283748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of psoriasis in people with hidradenitis suppurativa: A systematic review and meta-analysis.
    Gau SY; Preclaro IAC; Wei JC; Lee CY; Kuan YH; Hsiao YP; Juang SE; Ma KS
    Front Immunol; 2022; 13():1033844. PubMed ID: 36532043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Intense pulsed light treatment for hidradenitis suppurativa: a within-person randomized controlled trial].
    Andersen PL; Riis PT; Thorlacius L; Sigsgaard V; Nielsen CW; Chafranska L; Westergaard C; Jemec GB; Saunte DM
    Eur J Dermatol; 2020 Dec; 30(6):723-729. PubMed ID: 33300880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in the management of hidradenitis suppurativa in the Middle East region: a systematic review.
    Karvar M; Panayi AC; Alavi A; Baziar Z; Orgill DP
    Int J Dermatol; 2021 Nov; 60(11):e440-e448. PubMed ID: 33615455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complications of hidradenitis suppurativa after surgical management: A systematic review and meta-analysis.
    Tang B; Huang Z; Yi Q; Zheng X
    Int Wound J; 2023 Apr; 20(4):1253-1261. PubMed ID: 36207796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa.
    Fotiadou C; Vakirlis E; Ioannides D
    Clin Cosmet Investig Dermatol; 2016; 9():367-372. PubMed ID: 27799806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hidradenitis suppurativa].
    Tolaas E; Knudsen CW; Sviland L; Tønseth KA
    Tidsskr Nor Laegeforen; 2009 May; 129(10):992-6. PubMed ID: 19448752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hidradenitis suppurativa - symptoms, diagnostics, and therapy].
    Arenbergerová M; Dahmen RA; Arenberger P
    Cas Lek Cesk; 2017; 156(3):127-132. PubMed ID: 28722455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Itch in Hidradenitis Suppurativa/Acne Inversa: A Systematic Review.
    Agarwal P; Lunge SB; Shetty NS; Karagaiah P; Daveluy S; Ortega-Loayza AG; Tzellos T; Szepietowski JC; Zouboulis CC; Grabbe S; Goldust M
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of hidradenitis suppurativa.
    Drug Ther Bull; 2016 Sep; 54(9):102-5. PubMed ID: 27585997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathophysiology of hidradenitis suppurativa: An update.
    Prens E; Deckers I
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S8-11. PubMed ID: 26470623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hidradenitis suppurativa: a review of current treatment options.
    Lewandowski M; Świerczewska Z; Barańska-Rybak W
    Int J Dermatol; 2022 Sep; 61(9):1152-1164. PubMed ID: 35128643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Major gaps in understanding and treatment of hidradenitis suppurativa.
    Hoffman LK; Ghias MH; Garg A; Hamzavi IH; Alavi A; Lowes MA
    Semin Cutan Med Surg; 2017 Jun; 36(2):86-92. PubMed ID: 28538750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hidradenitis suppurativa and diabetes mellitus: A systematic review and meta-analysis.
    Bui TL; Silva-Hirschberg C; Torres J; Armstrong AW
    J Am Acad Dermatol; 2018 Feb; 78(2):395-402. PubMed ID: 29056237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment options in severe hidradenitis suppurativa].
    Mooij JE; van't Oost L; Leenarts MF; Mekkes JR
    Ned Tijdschr Geneeskd; 2011; 155():A1912. PubMed ID: 21426594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Managing patients with hidradenitis suppurativa.
    Ball SL; Tidman MJ
    Practitioner; 2016 May; 260(1793):25-9, 3. PubMed ID: 27382916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comorbidities of hidradenitis suppurativa: A review of the literature.
    Cartron A; Driscoll MS
    Int J Womens Dermatol; 2019 Dec; 5(5):330-334. PubMed ID: 31909152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.